| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 09/12/2001 | EP1132480A1 Method for producing halo-L-tryptophan |
| 09/12/2001 | EP1132478A2 Helper virus for the preparation of recombinant viral recombinants |
| 09/12/2001 | EP1132476A1 Inorganic Pyrophosphatases from Lepidoptera |
| 09/12/2001 | EP1132471A2 TNF-binding proteins |
| 09/12/2001 | EP1132469A2 Methods for separating nucleic acids from Protein-nucleic acids complexes |
| 09/12/2001 | EP1132467A2 Novel creatine amidinohydrolase, production thereof and use thereof |
| 09/12/2001 | EP1132466A1 Chicken anaemia viruses of low pathogenicity |
| 09/12/2001 | EP1132463A2 Cosmetic composition comprising an antagonist of the neuropeptide Y receptor |
| 09/12/2001 | EP1132404A2 Acylated insulin |
| 09/12/2001 | EP1132370A2 Process for producing n-substituted polyhydroxy nitrogen-containing heterocyles |
| 09/12/2001 | EP1131462A1 Analytical system based upon spore germination |
| 09/12/2001 | EP1131456A2 Vectors for gene mutagenesis and gene discovery by gene trapping |
| 09/12/2001 | EP1131451A2 Genes and vectors for conferring herbicide resistance in plants |
| 09/12/2001 | EP1131449A1 Method for identifying inhibitors of ipc synthase |
| 09/12/2001 | EP1131448A2 Producing antimicrobial cationic peptides as fusion proteins |
| 09/12/2001 | EP1131440A2 Process for oxidising terpenes |
| 09/12/2001 | EP1131418A1 Alpha-amylase variants |
| 09/12/2001 | EP1131413A1 Immortalized brain endothelial cells |
| 09/12/2001 | EP1131408A2 Cells, culture methods, and their use in autologous transplantation therapy |
| 09/12/2001 | EP1131407A1 Serum free medium for chondrocyte-like cells |
| 09/12/2001 | EP1131356A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 09/12/2001 | EP1131347A2 Product |
| 09/12/2001 | EP1131346A1 Heliobacter pylori antigen |
| 09/12/2001 | EP1131067A1 Composition and use of rar antagonists for promoting chondrogenesis |
| 09/12/2001 | EP1130969A1 Murf2 polypeptides and polynucleotides |
| 09/12/2001 | EP0839006B1 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
| 09/12/2001 | EP0804452B1 Recombinant c140 receptor, its agonists and antagonists |
| 09/12/2001 | EP0781348B1 Process for manufacturing cyclosporin a by highly productive fusant strain |
| 09/12/2001 | EP0687300B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
| 09/12/2001 | EP0666751B1 Mutants of hepatitis a virus strain hm-175 for use as hepatitis a vaccines |
| 09/12/2001 | EP0449856B1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 09/12/2001 | CN1312858A Bactericidal/permeability-increasing protein delation analogs |
| 09/12/2001 | CN1312723A Compound and method for diagnosis of tuberculosis |
| 09/12/2001 | CN1312704A Incorporation of exogenous lact'c bacteria into oral microflora |
| 09/12/2001 | CN1312374A Novel nucleic acid series of code gene sdhA, sdhB and sdhC |
| 09/12/2001 | CN1312373A Novel nucleic acid series of code zwa2 gene |
| 09/12/2001 | CN1312150A Process for high polymer synthesis to phenol compounds and the like and use thereof |
| 09/12/2001 | CN1070866C Superagonists and antagonists and superantagonists of H IL-6, and 3-D modelling method for their selection |
| 09/11/2001 | US6288306 Methods of selecting plants, plant tissue or plant cells resistant to a protoporphyrinogen oxidase inhibitor |
| 09/11/2001 | US6288035 Administering polypeptide as antitumor agent to treat melanoma; medical diagnosis |
| 09/11/2001 | US6288032 Polypeptides for osteoporosis and other bone disorder treatment |
| 09/11/2001 | US6287847 Biodegradation of metal cyanides |
| 09/11/2001 | US6287833 Arabinitol oxidoreductase; for use in the diagnosis of microorganismal infection |
| 09/11/2001 | US6287827 Fermentation of nocardia; administered to treat drug or antibiotic resistant grampositive bacterial infections |
| 09/11/2001 | US6287816 BMP-9 compositions |
| 09/11/2001 | US6287574 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/11/2001 | US6287557 Methods of gene therapy using herpes viral vectors expressing GM-CSF |
| 09/11/2001 | CA2021528C Muteins of human erythropoietin, the preparation thereof and the use thereof |
| 09/11/2001 | CA1341290C Method of genetically modifying plants |
| 09/09/2001 | CA2339910A1 Method for producing halo-l-tryptophan |
| 09/07/2001 | WO2001064931A1 Manufacture and purification of mycophenolic acid |
| 09/07/2001 | WO2001064930A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/07/2001 | WO2001064900A2 Aspartate carbamyltransferase as herbicidal target |
| 09/07/2001 | WO2001064899A2 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 09/07/2001 | WO2001064897A2 Mutant bacterial strains of the genus sphingonomas deficient in production of polyhydroxybutyrate and process of clarification of sphingans |
| 09/07/2001 | WO2001064857A1 Nitrilase from rhodococcus rhodochrous ncimb 11216 |
| 09/07/2001 | WO2001064849A1 Blood-brain barrier reconstruction model prepared by cocultivation |
| 09/07/2001 | WO2001064848A1 Method and apparatus for culturing cell or tissue |
| 09/07/2001 | WO2001064842A1 A novel obligately symbiotic thermophile symbiobacterium toebii sc-1 producing thermostable l-tyrosine phenol-lyase and l-tryptophan indole-lyase and a method for screening its relative bacteria |
| 09/07/2001 | WO2001064700A1 Novel macrolide compound jk |
| 09/07/2001 | WO2001064237A1 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof |
| 09/07/2001 | WO2001016294A3 Metal binding compounds and their use in cell culture medium compositions |
| 09/07/2001 | WO2001004273A3 Glucoamylase variant |
| 09/07/2001 | WO2000046389A9 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 09/07/2001 | CA2401699A1 Manufacture and purification of mycophenolic acid |
| 09/07/2001 | CA2401179A1 Mutant bacterial strains of the genus sphingomomas deficient in production of polyhydroxybutyrate and process of clarification of sphingans |
| 09/07/2001 | CA2400766A1 Aspartate carbamyltransferase as herbicidal target |
| 09/07/2001 | CA2400446A1 Nitrilase from rhodococcus rhodochrous ncimb 11216 |
| 09/06/2001 | US20010020010 Polypeptide |
| 09/06/2001 | US20010019837 Process for microbially oxidizing n-substituted glucamines |
| 09/06/2001 | US20010019731 Process for producing liquors |
| 09/06/2001 | US20010019720 Using 6-carbamoyl-2-pyridine carboxylic acid |
| 09/06/2001 | DE10107360A1 Novel metalloprotease containing a thrombospondin domain (MPTS protein) is useful to treat aggrecan associated disease including rheumatoid arthritis and osteoarthritis |
| 09/06/2001 | DE10010149A1 New nucleic acid encoding nitrilase, useful for converting aromatic nitriles to carboxylic acid, pharmaceutical intermediates, isolated from Rhodococcus rhodochrous |
| 09/05/2001 | EP1130109A1 Microbial process for preparation of optically active 3-Hydroxypyrrolidine derivatives |
| 09/05/2001 | EP1130107A1 Method of producing optically active N-methylamino acids |
| 09/05/2001 | EP1130098A2 Mammalian osteoregulins |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1130029A1 Protein amsh and cdna thereof |
| 09/05/2001 | EP1129351A2 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-$g(a) MEDIATED PATHWAY |
| 09/05/2001 | EP1129208A1 Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 09/05/2001 | EP1129200A2 Polypeptides having lactonohydrolase activity and nucleic acids encoding same |
| 09/05/2001 | EP1129197A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN |
| 09/05/2001 | EP1129183A2 Human glycine transporter type 2 |
| 09/05/2001 | EP1129181A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 09/05/2001 | EP1129177A1 Avipox vector coding an hiv antigen and a cytokine |
| 09/05/2001 | EP1129176A1 Embryonic stem cells |
| 09/05/2001 | EP1129175A2 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 09/05/2001 | EP1129112A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/05/2001 | EP1128843A2 Vaccine against papillomatous digital dermatitis (pdd) |
| 09/05/2001 | EP1128731A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 09/05/2001 | EP0792342B1 Use of specific lipolytic enzymes in detergent compositions |
| 09/05/2001 | EP0749471B1 A process for the reduction of the nucleic acid content of a fungus imperfectus |
| 09/05/2001 | EP0513090B1 Hepatitis a vaccines |
| 09/05/2001 | CN1311794A Aerothricin analogs, their prepn. and use |
| 09/05/2001 | CN1311333A Micro-organism method for prepn. of optical 3-hydroxy pyrrolidine derivatives |
| 09/05/2001 | CN1070611C Hybridoma cell lines and thier monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 09/05/2001 | CN1070533C yeast agglutination genes and yeast contg. same |
| 09/05/2001 | CN1070487C Hexahydronaphthalene ester derivatives, their prepn. and their therapeutic uses |
| 09/04/2001 | US6284949 A chimeric plant gene having a promoter for rna production, a dna sequence with insecticidally activity and a 3' non-translated dna sequence which causes polyadenylation of the rna; producing insect resistant plants |